Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
QHRD107 / Qianhong Bio-Pharma
NCT06532058: Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia	Recruiting	2	53	RoW	QHRD107 capsule，Venclexta and Azacitidine, CDK9 inhibitors	Changzhou Qianhong Bio-pharma Co., Ltd.	Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML)	02/25	05/25
CTR20190521: Clinical study on the safety of QHRD107 capsules	Completed	1	24	China	QHRD107 - Qianhong Bio-Pharma	Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.	Acute myeloid leukemia (AML)